SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)

PHASE2CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Overactive Bladder Syndrome (OABS)
Interventions
DRUG

Placebo

Placebo, 2 week duration.

DRUG

Placebo

Taken for the 8 week duration, in parallel with alternative arms (doses of 20, 40, 80 or 120mg SMP-986).

DRUG

SMP-986

Comparison of varying dosages (20, 40, 80 or 120mg) of SMP-986 against placebo. Dosing is to occur once daily, in the morning, for a duration of 8 weeks

Trial Locations (69)

10022

New York Urological Associates, PC, New York

10117

Gem. Praxis fur Urologie und Mannerheilkunde, Berlin

10138

East Tallinn Central Hospital, Tallinn

10611

West Tallinn Central Hospital, Tallinn

10787

Klinische Forschung Berlin, Berlin

11530

Accumed Research Associate, Garden City

12401

Hudson Valley Urology, Kingston

12601

Hudson Valley Urology, Poughkeepsie

12627

Urologische Praxis, Berlin

14057

Urologische Praxis, Berlin

15213

University of Pittsburg, Dept Urology, Pittsburgh

19230

Poststr. 25, Hagenow

20253

Urologische Gem. Praxis, Hamburg

21244

Urologische Praxis, Buchholz

22587

Urologische Praxisgemeinschaft, Hamburg

23294

National Clinical Research Inc, Richmond

28601

Unifour Medical Research, Hickory

28922

Fundacion Hospital Alcorcon, Madrid

30005

Atlanta Medical Research, Alpharetta

31059

Hopital Rangueil - CHU Toulouse, Toulouse

32308

Southern Research Group, Centre Point Boulevard, Tallahassee

33180

South Florida Medical Research, Aventura

33437

Visions Clinical Research, Boynton Beach

34474

Florida Healthcare Research, Ocala

37920

Volunteer Research Group, Knoxville

38320

Hospital Universitario, Santa Cruz de Tenerife

40211

Urologische Gem. Praxis, Düsseldorf

40470

Urologische Praxis, Düsseldorf

47179

Gem. Praxis Jacobi & Hellmis, Duisburg

51014

Tartu University Clinic, Tartu

60901

Urological Surgeons of IL, Kankakee

68167

Universitat Heidelberg, Mannheim

71106

Regional Urology, Shreveport

75571

Hopital Rothschild, Paris

75970

Hopital Tenon, Paris

78414

5920 Saratoga Boulevard, Corpus Christi

81241

Josef-Retzer-Str. 46, München

81679

Beckenboden Zentrum Munchen, München

85712

Visions Clinical Research, Tuscon

92108

9040 Friars Road, San Diego

92404

San Bernadino Urological Association Medical Group, San Bernadino

94027

Peninsula Urology Center, Atherton

99202

801 W. 5th Avenue, Spokane

04105

Urologische Praxis, Leipzig

04416

HauptstraBe 10, Markkleeberg

LV-1001

Medical Company ARS, Riga

LV-1002

P. Stradins Hospital, Riga

LT- 47144

Kaunas 2nd Clinical Hospital, Kaunas

LT- 50009

Kaunas Hospital, Kaunas

LT-08661

Vilnius Santariskes Clinics, Vilnius

85-168

Oddzial Urologii, Bydgoszcz

80-402

Akdemickie Centrum Kliniczne, Gdansk

40-752

Medical University of Selesia, Katowice

99-300

Non-public Healthcare Unit, Kutno

90-135

UI.G. Narutowicza 28, Lodz

93-338

Instytut Zdrowia Matki Polki, Lodz

20-950

University School of Medicine, Lublin

00-416

Clinical Dept of Urology, Medical Postgraduate Education, Warsaw

00-909

Military Institute of Medicine, Warsaw

02-005

Klinika Urologii Akademii, Warsaw

50-043

Ackademicki Szpital Klniczny, Wroclaw

08227

Hospital De Terrassa, Barcelona

08500

Servicio de Ginecologia, Barcelona

08950

Hospital Sant Joan De Deu, Barcelona

AB25 2NZ

Aberdeen Royal Infirmary, Aberdeen

CB2 2QQ

Addenbrooke's Hospital, Cambridge

CW1 4QJ

Leighton Hospital, Crewe

SE5 9RS

King's College Hospital, London

S10 2JF

The Royal Hallamshire Hospital, Sheffield

All Listed Sponsors
collaborator

Dainippon Sumitomo Pharma America

INDUSTRY

collaborator

ICON Clinical Research

INDUSTRY

collaborator

ClinPhone, Inc.

INDUSTRY

collaborator

Covance

INDUSTRY

collaborator

PPD Development, LP

INDUSTRY

lead

Sumitomo Pharma America, Inc.

INDUSTRY